Cargando…
Synthesis and biological evaluation of lycorine derivatives as dual inhibitors of human acetylcholinesterase and butyrylcholinesterase
BACKGROUND: Alzheimer’s disease (AD) is a neurologically degenerative disorder that affects more than 20 million people worldwide. The selective butyrylcholinesterase (BChE) inhibitors and bivalent cholinesterase (ChE) inhibitors represent new treatments for AD. FINDINGS: A series of lycorine deriva...
Autores principales: | Wang, Yue-Hu, Wan, Qin-Li, Gu, Cheng-Ding, Luo, Huai-Rong, Long, Chun-Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3782361/ https://www.ncbi.nlm.nih.gov/pubmed/22958411 http://dx.doi.org/10.1186/1752-153X-6-96 |
Ejemplares similares
-
Dual inhibition of acetylcholinesterase and butyrylcholinesterase enzymes by allicin
por: Kumar, Suresh
Publicado: (2015) -
Design, Synthesis, and Evaluation of Acetylcholinesterase and Butyrylcholinesterase Dual-Target Inhibitors against Alzheimer’s Diseases
por: Guo, Yan, et al.
Publicado: (2020) -
Inhibitors of Acetylcholinesterase and Butyrylcholinesterase Meet Immunity
por: Pohanka, Miroslav
Publicado: (2014) -
Synthesis and biological evaluation of aminomethyl and alkoxymethyl derivatives as carbonic anhydrase, acetylcholinesterase and butyrylcholinesterase inhibitors
por: Gulçin, İlhami, et al.
Publicado: (2017) -
Design, Synthesis, and Biological Evaluation of a New Series of Biphenyl/Bibenzyl Derivatives Functioning as Dual Inhibitors of Acetylcholinesterase and Butyrylcholinesterase
por: Wang, Dong-mei, et al.
Publicado: (2017)